Featured Articles
-
The Art And Science Of Tech Transfer – Transferring Vaccine Production
Facilities committed to prioritizing COVID-19 production are forcing non-COVID-19 vaccine makers to shift their production needs to other facilities, requiring a technology transfer in each case.
-
Oral Solutions & Suspensions: The Art Of Pharmacy
5/12/2022
Despite advantages, there are challenges associated with liquid dosage, such as stability and palatability, parameters that need to be considered in the design.
-
Optimizing Filling Technology To Minimize API Loss
New advances in filling technology offer solutions that can minimize lost API and eliminate sources of risk while still meeting the regulatory requirements for testing and quality assurance.
-
Five Trends Driving Lyophilization
9/20/2022
Learn more about the trends driving the need for lyophilization: biopharmaceuticals, scalability, a growing geriatric population, rising chronic diseases, and cold chain and storage.
-
Snapshot Of The Parenteral Drug Delivery Market
6/17/2022
Growth in the development of parenteral drugs is driving demand for advanced drug delivery devices such as prefilled syringes, autoinjectors, and pen-injectors, growing segments in fill-finish manufacturing.
-
Manage Risks In Development And Manufacture Of Potent Pharma Products
6/17/2019
Given the variety of potent drugs in development, outsourcing the development and manufacturing to a CDMO experienced in handling a range of products, in a multi-use facility, is an effective strategy.
-
Tech Transfer For Oral Products
With the right CDMO, a proper tech transfer offers an opportunity to re-examine quality, process procedures, and supply chain issues, including provider partnerships.
-
The Value Of Orphan Drug Designation
More than 90% of rare diseases still have no FDA-approved treatment, even though rare diseases affect more than 25 million Americans. Despite the opportunities in the orphan drug market, there are challenges that may act as barriers to entry.
-
Enhancing Oral Solid Dose Solubility And Bioavailability With ASD
Spray-dried ASD (amorphous solid dispersions) technology may be the catalyst needed to overcome solubility and bioavailability challenges for your promising oral solid dose candidate.